Teva Pharmaceuticals has agreed to pay $450m to settle allegations that it violated several government acts and a raft of ...
Teva Pharmaceuticals TEVA-0.87%decrease; red down pointing triangle will pay $450 million to resolve allegations that ... Department on Thursday said the settlement amount was based on the company ...
Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (“Teva”) agreed to pay $450 million to resolve two matters that allege ...
Teva Pharmaceutical Industries Ltd has agreed to pay $450 million to resolve allegations it used charities that help cover ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
Teva Pharmaceuticals Agrees to Pay $450 Million to Resolve FCA Claims - On October 10, the US Department of Justice (DOJ) ...
Today's decision to impose an antitrust fine on Teva for disparagement and misuse of the patent system reaffirms the ...
The European Commission has fined Teva , the world's largest generic drugmaker, 462.6 million euros ($503 million) for abusing its dominant position to delay competition to its blockbuster multiple ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
In June 2023, Alvotech and Teva announced that they had reached a settlement and license agreement with the manufacturer of the reference biologic, granting a license entry date for Selarsdi in ...